- Home
- IMNN vs ARTW Comparison
IMNN vs ARTW Comparison
Compare IMNN & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNN | ARTW |
|---|---|---|
| Founded | 1982 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 12.4M |
| IPO Year | 2000 | 1996 |
Fundamental Metrics
Financial Performance| Metric | IMNN | ARTW |
|---|---|---|
| Price | $3.17 | $2.25 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $182.61 | N/A |
| AVG Volume (30 Days) | 26.2K | ★ 37.9K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.00 | ★ 233.33 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $22,975,408.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.35 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.37 | $1.43 |
| 52 Week High | $9.32 | $4.69 |
Technical Indicators
Market Signals| Indicator | IMNN | ARTW |
|---|---|---|
| Relative Strength Index (RSI) | 59.53 | 43.05 |
| Support Level | $3.53 | $2.21 |
| Resistance Level | $3.62 | $2.49 |
| Average True Range (ATR) | 0.21 | 0.10 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 92.98 | 14.06 |
Price Performance
Historical ComparisonAbout IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.